Therapeutic options and results for the management of minimally invasive carcinoma of the breast: Influence of axillary dissection for treatment of T1a and T1b lesions

Journal of the American College of Surgeons

Volumn 183, Issue 6, 1996, Pages 575-582

  White, Russell E ^a   Vezeridis, Michael P ^a   Konstadoulakis, Manoussos ^a   Cole, Bernard F ^a   Wanebo, Harold J ^a   Bland, Kirby I ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURGICAL TECHNIQUE; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0029852615     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Silverstein, M. J., Gierson, E. D., Waisman, J. R., and others. Axillary lymph node dissection for T1a breast carcinoma. Cancer, 1994, 73: 664-667.
2. Cady, B., Stone, M. D., and Wayne, J. New therapeutic possibilities in primary invasive breast cancer. Ann. Surg., 1993, 218: 338-349.
3. Halverson, K. J., Taylor, M. E., Perez, C. A., and others. Management of the axilla in patients with breast cancers one centimeter or smaller. Am. J. Clin. Oncol., 1994, 17: 461-466.
4. Lin, P. P., Allison, D. C., Wainstock, J., and others. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J. Clin. Oncol., 1993, 11: 1536-1544.
5. Ranaboldo, C. J., Mitchel, A., Royle, G. T., and others. Axillary nodal status in women with screen-detected breast cancer. Eur. J. Surg. Oncol., 1993, 19: 130-133.
6. Walls, J., Boggis, C. R. M., Wilson, M., and others. Treatment of the axilla in patients with screen-detected breast cancer. Br. J. Surg., 1993, 80: 436-438.
7. Chadha, M., Chabon, A. B., Friedmann, P., and Vikram, B. Predictors of axillary lymph node metastases in patients with Tl breast cancer: a multivariate analysis. Cancer, 1994, 73: 350-353.
8. Deckers, P. J. Axillary dissection in breast cancer: when, why, how much, and or how long? Another operation soon to be extinct? J. Surg. Oncol., 1991, 48: 217-219.
9. Silverstein, M. J., Gierson, E. D., Colburn, W. J., and others. Axillary lymphadenectomy for intraductal carcinoma of the breast. Surg. Gynecol. Obstet., 1991, 172: 211-214.
10. Frykberg, E. R., Ames, F. C., and Bland, K. I. Current concepts for management of early (in situ and occult invasive) breast carcinoma. In: The Breast: Comprehensive Management of Benign and Malignant Diseases. Edited by K. I. Bland and E. M. Copeland III. Pp. 731-752. Philadelphia: W. B. Saunders Co., 1991.
11. Frykberg, E. R., and Bland, K. I. Management of in situ and minimally invasive breast carcinoma. World J. Surg., 1994, 18: 45-57.
12. Cady, B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer, 1994, 73: 505-508.
13. Calle, R., Vilcoq, J. R., Pilleron, J. P., and others. Conservative treatment of operable breast carcinoma by irradiation with or without limited surgery: ten year results. In: Conservative Management of Breast Cancer. Edited by J. R. Harris, S. Hellman, and W. Silen. Pp. 3-9. Phildelphia: J. B. Lippincott, Co., 1983.
14. Cabanes, P. A., Salmon, R. J., Vilcoq J. R., and others. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet, 1992, 339: 1245-1248.
15. Valagussa, P., Bonadonna, G., and Veronesi, U. Patterns of relapse and survival following radical mastectomy. Cancer, 1977, 39: 2827-2839.
16. Nemoto, T., Vana, J., Bedwani, R. N., and others. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer, 1980, 45: 2917-2924.
17. Fisher, B., Slack, N., Katrych, D., and Wolmark, N. Ten-year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg. Gynecol. Obstet., 1975, 140: 528-534.
18. Margolese, R. G. Axillary surgery in breast cancer: there still is a debate. Eur. J. Cancer, 1993, 29A: 801.
19. Joensuu, H., Toikkanen, S., and Klemi, P. J. DNA index and S-phase fraction and their combination as prognostic factors in operable ductal breast carcinoma. Cancer, 1990, 66: 331-340.
20. Kallioniemi, O., Blanco, G., Alavaikka, M., and others. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer, 1988, 62: 2183-2190.
21. Clark, G. M., Dressier, L. G., Owens, M. A., and others. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N. Engl. J. Med., 1989, 320: 627-633.
22. Ellis, C. N., Frey, E. S., Burnette, J. J., and others. The content of tumor DNA as an indicator of prognosis in patients with TlNOMO and T2N0M0 carcinoma of the breast. Surgery, 1989, 106: 133-138.
23. Fisher, B., Redmond, C., Fisher, E. R., and others. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J. Clin. Oncol., 1988, 6: 1076-1087.
24. Rose, C. M., Botnick, L. E., Weinstein, M., and others. Axillary sampling in the definitive treatment of breast cancer by radiation therapy and lumpectomy. Int. J. Radiat. Oncol. Biol. Phys., 1983, 9: 339-344.
25. Carter, C. L., Allen, C., and Henson, D. E. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer, 1989, 63: 181-187.
26. Dowlatshahi, K., Snider, H., and Kirn, R. Axillary node status in nonpalpable breast cancer. Ann. Surg. Oncol., 1995, 2: 424-428.
27. Cady, B., Stone, M. D., Schuler, J., and others. The new era in breast cancer: invasion, size and nodal involvement dramatically decreasing as a result of mammographic screening. Arch. Surg., 1996, 131: 301-308.
28. Harris, J. R., and Osteen, R. T. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res. Treat., 1985, 5: 17-21.
29. Sacks, N. P. M., Baum, M., and Barr, L. C. Axillary node dissection in breast cancer (Letter to the Editor). Lancet, 1992, 340: 247.
30. Oza, A. M., Rawlings, G., and Tannock, I. F. Axillary node dissection in breast cancer (Letter to the Editor). Lancet, 1992, 340: 247.
31. Whitaker, S. J., Huddart, R. A., Wilson, C. B. J. H., and Yarnold, J. R. Axillary node dissection in breast cancer (Letter to the Editor). Lancet, 1992, 340: 247.